261 related articles for article (PubMed ID: 16554039)
1. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
Ishibashi O; Yamagishi T; Hanada K; Kawashima H
Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta acts as a dominant regulator of estrogen signaling.
Pettersson K; Delaunay F; Gustafsson JA
Oncogene; 2000 Oct; 19(43):4970-8. PubMed ID: 11042684
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
7. Ligand-independent activation of the estrogen receptors alpha and beta by mutations of a conserved tyrosine can be abolished by antiestrogens.
Tremblay GB; Tremblay A; Labrie F; Giguère V
Cancer Res; 1998 Mar; 58(5):877-81. PubMed ID: 9500442
[TBL] [Abstract][Full Text] [Related]
8. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta.
Rickard DJ; Monroe DG; Ruesink TJ; Khosla S; Riggs BL; Spelsberg TC
J Cell Biochem; 2003 Jun; 89(3):633-46. PubMed ID: 12761896
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
10. Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies.
Gaido KW; Maness SC; McDonnell DP; Dehal SS; Kupfer D; Safe S
Mol Pharmacol; 2000 Oct; 58(4):852-8. PubMed ID: 10999957
[TBL] [Abstract][Full Text] [Related]
11. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
Hall JM; McDonnell DP
Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
[TBL] [Abstract][Full Text] [Related]
12. Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands.
Balaguer P; Boussioux AM; Demirpence E; Nicolas JC
Luminescence; 2001; 16(2):153-8. PubMed ID: 11312541
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
14. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta.
Vanacker JM; Pettersson K; Gustafsson JA; Laudet V
EMBO J; 1999 Aug; 18(15):4270-9. PubMed ID: 10428965
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W
J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935
[TBL] [Abstract][Full Text] [Related]
17. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems.
Kuiper GG; Shughrue PJ; Merchenthaler I; Gustafsson JA
Front Neuroendocrinol; 1998 Oct; 19(4):253-86. PubMed ID: 9799586
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and its application of a reporter-based screening model for discovering new ligands of estrogen receptor alpha subtypes].
Sun Z; Lu QJ; Wen LQ; Guo SM; Chen YY; Liu WJ
Yao Xue Xue Bao; 2000 Oct; 35(10):747-51. PubMed ID: 11372440
[TBL] [Abstract][Full Text] [Related]
19. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
[TBL] [Abstract][Full Text] [Related]
20. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.
Maggiolini M; Donzé O; Jeannin E; Andò S; Picard D
Cancer Res; 1999 Oct; 59(19):4864-9. PubMed ID: 10519397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
